• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类白细胞抗原 F 座相邻转录本 10 过表达扰乱 WISP1 蛋白和 mRNA 表达,促进肝癌进展。

Human Leukocyte Antigen F Locus Adjacent Transcript 10 Overexpression Disturbs WISP1 Protein and mRNA Expression to Promote Hepatocellular Carcinoma Progression.

机构信息

Department of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang, China.

Jiangxi Province Engineering Research Center of Hepatobiliary Disease, Nanchang, China.

出版信息

Hepatology. 2018 Dec;68(6):2268-2284. doi: 10.1002/hep.30105. Epub 2018 Nov 8.

DOI:10.1002/hep.30105
PMID:29790184
Abstract

Recently, studies on transcriptome-proteome relationships have revealed mRNA/protein expression discordance for certain genes and speculated that protein posttranslational modification (PTM) may be involved. However, there is currently no evidence to support this hypothesis. Wnt-induced secreted protein-1 (WISP1) is the downstream target gene of β-catenin and plays an important role in tumorigenesis and progression, but the expression and role of WISP1 in different tumor types are controversial. Here, we first confirmed that WISP1 protein expression was significantly down-regulated in hepatocellular carcinoma (HCC) tissue and could be an independent predictor of poor prognosis for patients with HCC. In vivo and in vitro evidence was provided that WISP1 can suppress HCC cell proliferation. Further studies have found that low WISP1 protein expression was related to expression of human leukocyte antigen F locus adjacent transcript 10 (FAT10), a specific ubiquitin-like protein with both degradation and stabilization functions, which plays an important role in PTM. FAT10 overexpression facilitated WISP1 degradation by FAT10ylation to decrease WISP1 protein expression, thus promoting HCC proliferation. Interestingly, we found and demonstrated that FAT10 overexpression could result in WISP1 protein/mRNA expression discordance, with protein expression decreasing while mRNA expression increased. The underlying mechanism is that FAT10 exerts substrate stabilization and degradation functions simultaneously, while FAT10 overexpression promotes WISP1 mRNA expression by stabilizing β-catenin and directly degrades WISP1 protein. Conclusion: Our study demonstrated that overexpression of FAT10 results in expression discordance between WISP1 protein and mRNA, thereby promoting HCC progression by down-regulating WISP1 protein expression.

摘要

最近,关于转录组-蛋白质组关系的研究揭示了某些基因的 mRNA/蛋白质表达不一致,并推测蛋白质翻译后修饰(PTM)可能与之相关。然而,目前尚无证据支持这一假设。Wnt 诱导的分泌蛋白-1(WISP1)是β-连环蛋白的下游靶基因,在肿瘤发生和进展中发挥重要作用,但 WISP1 在不同肿瘤类型中的表达和作用仍存在争议。在这里,我们首先证实 WISP1 蛋白表达在肝细胞癌(HCC)组织中显著下调,并且可以作为 HCC 患者预后不良的独立预测因子。提供了体内和体外证据表明 WISP1 可以抑制 HCC 细胞增殖。进一步的研究发现,低 WISP1 蛋白表达与人类白细胞抗原 F 座相邻转录物 10(FAT10)的表达相关,FAT10 是一种具有降解和稳定功能的特定泛素样蛋白,在 PTM 中发挥重要作用。FAT10 过表达通过 FAT10 化促进 WISP1 降解,从而降低 WISP1 蛋白表达,从而促进 HCC 增殖。有趣的是,我们发现并证明 FAT10 过表达可导致 WISP1 蛋白/mRNA 表达不一致,表现为蛋白表达降低而 mRNA 表达增加。其潜在机制是 FAT10 同时发挥底物稳定和降解功能,而 FAT10 过表达通过稳定 β-连环蛋白并直接降解 WISP1 蛋白来促进 WISP1 mRNA 表达。结论:本研究表明,FAT10 的过表达导致 WISP1 蛋白与 mRNA 表达不一致,从而通过下调 WISP1 蛋白表达促进 HCC 进展。

相似文献

1
Human Leukocyte Antigen F Locus Adjacent Transcript 10 Overexpression Disturbs WISP1 Protein and mRNA Expression to Promote Hepatocellular Carcinoma Progression.人类白细胞抗原 F 座相邻转录本 10 过表达扰乱 WISP1 蛋白和 mRNA 表达,促进肝癌进展。
Hepatology. 2018 Dec;68(6):2268-2284. doi: 10.1002/hep.30105. Epub 2018 Nov 8.
2
Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.泛素样蛋白 FAT10 通过修饰β-连环蛋白降解促进肝癌的侵袭和转移。
Cancer Res. 2014 Sep 15;74(18):5287-300. doi: 10.1158/0008-5472.CAN-14-0284. Epub 2014 Jul 23.
3
As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3β pathway.作为一个独立的预后因素,FAT10 通过 Akt/GSK3β 通路促进乙型肝炎病毒相关肝细胞癌的进展。
Oncogene. 2014 Feb 13;33(7):909-20. doi: 10.1038/onc.2013.236. Epub 2013 Jul 1.
4
High expression of WISP1 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma.WISP1 高表达促进肝癌转移并预测不良预后。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10445-10451. doi: 10.26355/eurrev_202010_23396.
5
High expression of WISP1 in colon cancer is associated with apoptosis, invasion and poor prognosis.WISP1在结肠癌中的高表达与细胞凋亡、侵袭及不良预后相关。
Oncotarget. 2016 Aug 2;7(31):49834-49847. doi: 10.18632/oncotarget.10486.
6
The ubiquitin-like protein FAT10 in hepatocellular carcinoma cells limits the efficacy of anti-VEGF therapy.肝癌细胞中的泛素样蛋白 FAT10 限制了抗 VEGF 治疗的疗效。
J Adv Res. 2024 May;59:97-109. doi: 10.1016/j.jare.2023.06.006. Epub 2023 Jun 15.
7
Ubiquitin-like protein FAT10: A potential cardioprotective factor and novel therapeutic target in cancer.类泛素蛋白FAT10:一种潜在的心脏保护因子及癌症新治疗靶点
Clin Chim Acta. 2020 Nov;510:802-811. doi: 10.1016/j.cca.2020.09.016. Epub 2020 Sep 16.
8
Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma.核糖体蛋白 S15a 通过增强 Wnt/β-连环蛋白诱导的肝细胞癌中 FGF18 的表达促进肿瘤血管生成。
Oncogene. 2018 Mar;37(9):1220-1236. doi: 10.1038/s41388-017-0017-y. Epub 2017 Dec 15.
9
Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma.下调的FSTL5通过影响肝细胞癌中的Wnt/β-连环蛋白信号通路促进细胞增殖和存活。
Int J Clin Exp Pathol. 2015 Mar 1;8(3):3386-94. eCollection 2015.
10
Ubiquitin-like protein FAT10 promotes bladder cancer progression by stabilizing survivin.类泛素蛋白FAT10通过稳定生存素促进膀胱癌进展。
Oncotarget. 2016 Dec 6;7(49):81463-81473. doi: 10.18632/oncotarget.12976.

引用本文的文献

1
Mechanistic insights into the role of FAT10 in modulating NCOA4-mediated ferroptosis in pancreatic acinar cells during acute pancreatitis.急性胰腺炎期间FAT10在调节胰腺腺泡细胞中NCOA4介导的铁死亡作用的机制研究
Cell Death Dis. 2025 May 15;16(1):385. doi: 10.1038/s41419-025-07715-9.
2
LAPTM4B enhances the stemness of CD133 liver cancer stem-like cells via WNT/β-catenin signaling.LAPTM4B通过WNT/β-连环蛋白信号通路增强CD133肝癌干细胞样细胞的干性。
JHEP Rep. 2024 Dec 20;7(4):101306. doi: 10.1016/j.jhepr.2024.101306. eCollection 2025 Apr.
3
WISP1 Inhibits Hepatocellular Carcinoma Cell Proliferation by Promoting CyclinD1 Ubiquitination and Downregulating its Expression.
WISP1通过促进细胞周期蛋白D1泛素化并下调其表达来抑制肝癌细胞增殖。
Turk J Gastroenterol. 2024 Dec 16;36(4):247-254. doi: 10.5152/tjg.2024.23524.
4
An overview of CCN4 (WISP1) role in human diseases.CCN4(WISP1)在人类疾病中的作用概述。
J Transl Med. 2024 Jun 27;22(1):601. doi: 10.1186/s12967-024-05364-8.
5
Prognostic significance of FAT10 expression in malignant tumors: a systematic review and meta-analysis.FAT10 表达在恶性肿瘤中的预后意义:系统评价和荟萃分析。
Future Oncol. 2024;20(21):1505-1514. doi: 10.1080/14796694.2024.2357531. Epub 2024 Jun 12.
6
FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma.FAT10 通过上调肝癌中 PD-L1 的表达诱导免疫抑制。
Apoptosis. 2024 Oct;29(9-10):1529-1545. doi: 10.1007/s10495-024-01982-1. Epub 2024 Jun 2.
7
Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation.泛素特异性蛋白酶 54 通过调节 GLUT1 介导的有氧糖酵解来抑制肺腺癌的进展,其方式为修饰 p53 的降解。
Oncogene. 2024 Jun;43(26):2025-2037. doi: 10.1038/s41388-024-03047-8. Epub 2024 May 14.
8
FAT10 mediates the sorafenib-resistance of hepatocellular carcinoma cells by stabilizing E3 ligase NEDD4 to enhance PTEN/AKT pathway-induced autophagy.FAT10通过稳定E3连接酶NEDD4以增强PTEN/AKT途径诱导的自噬,介导肝癌细胞对索拉非尼的耐药性。
Am J Cancer Res. 2024 Apr 15;14(4):1523-1544. doi: 10.62347/EPIT4481. eCollection 2024.
9
Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification.肝细胞癌的铜死亡相关分子分类及基因特征与实验验证
Transl Cancer Res. 2024 Mar 31;13(3):1268-1289. doi: 10.21037/tcr-23-1876. Epub 2024 Mar 27.
10
Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation.去泛素化酶PSMD7通过修饰SOX2降解激活Nocth1途径促进胰腺癌进展。
Cell Biosci. 2024 Mar 17;14(1):35. doi: 10.1186/s13578-024-01213-9.